Bruton's tyrosine kinase phosphorylates Toll-like receptor 3 to initiate antiviral response

Toll-like receptor 3 (TLR3) mediates antiviral response by recognizing double-stranded RNA. Its cytoplasmic domain is tyrosine phosphorylated upon ligand binding and initiates downstream signaling via the adapter TIR-containing adaptor inducing interferon-β (TRIF). However, the kinase responsible fo...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 109; no. 15; pp. 5791 - 5796
Main Authors Lee, Koon-Guan, Xu, Shengli, Kang, Zi-Han, Huo, Jianxin, Huang, Mei, Liu, Dingxiang, Takeuchi, Osamu, Akira, Shizuo, Lam, Kong-Peng
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 10.04.2012
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Toll-like receptor 3 (TLR3) mediates antiviral response by recognizing double-stranded RNA. Its cytoplasmic domain is tyrosine phosphorylated upon ligand binding and initiates downstream signaling via the adapter TIR-containing adaptor inducing interferon-β (TRIF). However, the kinase responsible for TLR3 phosphorylation remains unknown. We show here that Bruton's tyrosine kinase (BTK)-deficient macrophages failed to secrete inflammatory cytokines and IFN-β upon TLR3 stimulation and were impaired in clearing intracellular dengue virus infection. Mutant mice were also less susceptible to d-galactosamine/p(I:C)-induced sepsis. In the absence of BTK, TLR3-induced phosphoinositide 3-kinase (PI3K), AKT and MAPK signaling and activation of NFκB, IRF3, and AP-1 transcription factors were all defective. We demonstrate that BTK directly phosphorlates TLR3 and in particular the critical Tyr759 residue. BTK point mutations that abrogate or led to constitutive kinase activity have opposite effects on TLR3 phosphorlation. Loss of BTK also compromises the formation of the downstream TRIF/receptor-interacting protein 1 (RIP1)/TBK1 complex. Thus, BTK plays a critical role in initiating TLR3 signaling.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Author contributions: K.-G.L. and K.-P.L. designed research; K.-G.L., S.X., Z.-H.K., J.H., and M.H. performed research; O.T. and S.A. contributed new reagents/analytic tools; D.L. and K.-P.L. analyzed data; and K.-G.L. and K.-P.L. wrote the paper.
Edited by Ruslan Medzhitov, Yale University School of Medicine, New Haven, CT, and approved March 5, 2012 (received for review November 23, 2011)
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.1119238109